52991-03-4 Usage
Description
Phenethylamine, beta-methyl-, hydrochloride, (+-)is a naturally occurring monoamine alkaloid and trace amine neurotransmitter that exhibits potent central nervous system stimulant and anorectic properties. It is a chemical compound within the phenethylamine class and serves as a precursor to vital neurotransmitters like dopamine and norepinephrine. Studies have explored its potential therapeutic applications in treating conditions such as depression, obesity, and attention deficit hyperactivity disorder.
Uses
Used in Pharmaceutical Industry:
Phenethylamine, beta-methyl-, hydrochloride, (+-)is used as a therapeutic agent for the treatment of various conditions due to its ability to modulate neurotransmitter levels and stimulate the central nervous system. Its potential applications include the management of depression, obesity, and attention deficit hyperactivity disorder, where it can help regulate mood, suppress appetite, and improve focus and attention.
Used in Research and Development:
In the scientific community, Phenethylamine, beta-methyl-, hydrochloride, (+-)is utilized as a research compound to study the effects of trace amine neurotransmitters on the central nervous system. Its role as a precursor to important neurotransmitters like dopamine and norepinephrine makes it a valuable tool for understanding the underlying mechanisms of various neurological and psychiatric disorders.
Used in Neurotransmitter Synthesis:
Phenethylamine, beta-methyl-, hydrochloride, (+-)is used as a precursor in the synthesis of neurotransmitters, playing a crucial role in the production of essential compounds that regulate mood, motivation, and cognitive function. Its involvement in the synthesis of dopamine and norepinephrine highlights its importance in maintaining proper neurotransmission and overall brain health.
Used in Drug Development:
Phenethylamine, beta-methyl-, hydrochloride, (+-)is employed in the development of new drugs targeting the central nervous system. Its unique properties and potential therapeutic applications make it a promising candidate for the creation of novel medications aimed at treating a range of neurological and psychiatric conditions.
Used in Nutritional Supplements:
As an appetite suppressant and mood enhancer, Phenethylamine, beta-methyl-, hydrochloride, (+-)is used in the formulation of nutritional supplements designed to support weight management and improve mental well-being. Its inclusion in these products can help individuals control their appetite and maintain a positive mood while working towards their health and fitness goals.
Check Digit Verification of cas no
The CAS Registry Mumber 52991-03-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,9 and 1 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 52991-03:
(7*5)+(6*2)+(5*9)+(4*9)+(3*1)+(2*0)+(1*3)=134
134 % 10 = 4
So 52991-03-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N.ClH/c1-8(7-10)9-5-3-2-4-6-9;/h2-6,8H,7,10H2,1H3;1H
52991-03-4Relevant articles and documents
Two-dimensional perovskite chiral ferromagnets
Li, Xiang-Yang,Liu, Xiao-Fei,Shao, Xiangfeng,Sun, Bing,Yang, Dezheng,Zhang, Hao-Li,Zhang, Yamin
, p. 8914 - 8920 (2020/12/09)
Magnetic molecular materials with a chiral configuration are attractive candidates for sensing, information storage, and spintronics. Herein, we report the first example of two-dimensional hybrid perovskite chiral ferromagnets, (R-MPEA)2CuCl4 and (S-MPEA)2CuCl4. These two compounds exhibit strong oppositely signed circular dichroism signals and clear ferromagnetic behaviors. Magnetic measurements revealed high saturation magnetization up to 12.5 emu g-1. The coexistence of strong chirality and ferromagnetism enabled successful study on their magneto-chiral dichroism spectra. These findings demonstrate a new materials platform for future magneto-optical and spintronic applications, providing insights to the structure-property correlation of chiral ferromagnetic perovskite.
AMPA RECEPTOR POTENTIATORS
-
Page/Page column 6, (2008/12/06)
The present invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof which is useful for the treatment of conditions associated with glutamate hypofunction, such as psychiatric and neurological disorders.
Sulfonamide derivatives
-
Page 8-12, (2010/02/05)
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof which is useful for the treatment of conditions associated with glutamate hypofunction, such as psychiatric and neurological disorders.
